brain4care is awarded with independent HIPAA Compliance certification

Atlanta, July 2024 — brain4care, a deeptech pioneer in non-invasive monitoring of intracranial pressure, is pleased to announce the successful certification of compliance with the Health Insurance Portability and Accountability Act (HIPAA) as their continued commitment of providing a secure data environment for their? customers.

HIPAA isa set of regulatory standards governing the security, privacy, and integrity of

sensitive healthcare data called protected health information (PHI), any individually

identifiable healthcare-related information. If vendors who service healthcare clients come into

contact with PHI in any way, those vendors must be HIPAA compliant.

After a rigorous assessment process overseen by Johanson Group LLP, brain4care has

successfully met the stringent standards mandated by the Health Insurance

Portability and Accountability Act (HIPAA). This milestone underscores brain4care's

commitment to safeguarding sensitive patient information, ensuring data security, and

maintaining the highest standards of confidentiality within the healthcare sector.

Johanson Group attested to brain4care’s information security controls meeting the

leading industry standards. Johanson Group specializes in HIPAA compliance and provides audit and professional services to public and private companies, large and small, in a variety of industries.

At its core,brain4care? is committed to? data integrity and

security, a fundamental part of how brain4care manages user identity. HIPAA compliance

represents a commitment that secure systems and controls are maintained by the organization

on an ongoing basis.

About brain4care

brain4care is a deeptech pioneer in non-invasive monitoring of intracranial pressure. The technology consists of a platform with artificial intelligence that processes data obtained by a sensor and generates reports to assist doctors in decision-making. The service is offered via a subscription-based SaaS (software as a service).?

The non-invasive technology captures cranial micro expansions that generate a surrogate ICP and derived parameters waveform that shows changes in intracranial volume and pressure. Headaches, cerebral edema, tumors, hydrocephalus, and reversible dementias are examples of conditions related to this issue that can benefit from the use of this technology.

brain4care's technology allows doctors to evaluate and monitor changes in intracranial pressure, in patients in clinics and hospitals, with the objective to aid in screening, diagnosis of associated pathologies, and also as an additional information used for appropriate actions, such as reducing risk in the management of cerebral edema, reducing? potential neurological damage and sequelae.

The technology is FDA cleared in the US and? Anvisa approved in Brazil, — where it is present in 76 hospitals and clinics and brain4care is actively moving towards international market expansion.